Skip to Main Content
Lenette Lu, M.D.,  Ph.D.

Lenette Lu, M.D., Ph.D.

Assistant Professor

School
Medical School
Department
Internal Medicine | Immunology
Graduate Programs
Immunology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Lenette Lu, M.D., Ph.D., is an Assistant Professor in the Department of Internal Medicine and a member of its Division of Infectious Diseases and Geographic Medicine. She holds a secondary appointment in the he Department of Immunology.

    My long-term goal is to translate observations from humans to models of disease in order to further inform and direct human studies, realizing the remarkable potential in the synergy between science and medicine.

    Originally from China, Dr. Lu holds a bachelor’s degree in biology and Asian studies from Swarthmore College in Pennsylvania, where she graduated with high honors. She earned her medical degree and her doctoral degree in molecular virology at Case Western Reserve University School of Medicine in Cleveland. She completed an internal medicine residency at New York-Presbyterian/Weill Cornell Medical Center and a clinical fellowship in infectious diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. She completed a postdoctoral research fellowship at Harvard School of Public Health and the Ragon Institute of Mass General, MIT, and Harvard.

    Certified by the American Board of Internal Medicine in infectious diseases, Dr. Lu joined the UT Southwestern faculty in 2019.

    Dr. Lu’s research focuses on how antibodies interface with the host microbe in infectious diseases. Her studies focus on Mycobacterium tuberculosis (Mtb), the bacterium that infects one out of four people worldwide and causes tuberculosis. Her goal is to increase understanding of the immune response to infection and, ultimately, to translate observations from humans to models of disease to further inform and direct human studies that could direct diagnostic, therapeutic, and vaccine development.

    Dr. Lu is a member of the American Association of Immunologists and the Infectious Diseases Society of America. In 2021, she received the American Society for Clinical Investigation’s Young Physician Scientist Award.

  • Education
    Other Post Graduate Training
    Case Western Reserve University (2009)
    Graduate School
    Case Western Reserve University (2009), Molecular Virology
    Medical School
    Case Western Reserve University (2010)
    Residency
    New York Presbyterian Hospital, Cornell Campus (2013), Internal Medicine
    Fellowship
    Massachusetts General Hospital (2015), Infectious Diseases
  • Research Interest
    • Antibody Effector Functions
    • Antibody Glycosylation
    • Host Microbial Interactions
    • Humoral Immunity
    • Tuberculosis
  • Publications

    Star Featured Publications

    Featured Featured Featured
    BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age.
    Bates TA, Lu P, Kang YJ, Schoen D, Thornton M, McBride SK, Park C, Kim D, Messer WB, Curlin ME, Tafesse FG, Lu LL, Cell Rep 2022 Oct 41 4 111544
    Engineering the supernatural: monoclonal antibodies for challenging infectious diseases.
    Grace PS, Gunn BM, Lu LL, Curr Opin Biotechnol 2022 Oct 78 102818
    Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis.
    Carpenter SM, Lu LL, Front Immunol 2022 13 830482
    Antibody Subclass and Glycosylation Shift Following Effective TB Treatment.
    Grace PS, Dolatshahi S, Lu LL, Cain A, Palmieri F, Petrone L, Fortune SM, Ottenhoff THM, Lauffenburger DA, Goletti D, Joosten SA, Alter G, Front Immunol 2021 12 679973
    Unique repertoire of anti-carbohydrate antibodies in individual human serum.
    Luetscher RND, McKitrick TR, Gao C, Mehta AY, McQuillan AM, Kardish R, Boligan KF, Song X, Lu L, Heimburg-Molinaro J, von Gunten S, Alter G, Cummings RD, Sci Rep 2020 09 10 1 15436
    Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
    Lu LL, Das J, Grace PS, Fortune SM, Restrepo BI, Alter G, J. Infect. Dis. 2020 Feb
    Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
    Lu LL, Smith MT, Yu KKQ, Luedemann C, Suscovich TJ, Grace PS, Cain A, Yu WH, McKitrick TR, Lauffenburger D, Cummings RD, Mayanja-Kizza H, Hawn TR, Boom WH, Stein CM, Fortune SM, Seshadri C, Alter G, Nat. Med. 2019 Jun
  • Books

    Featured 

    Babesiosis. In Diagnostic Pathology: Infectious DIseases

    Lu, L., and Milner, D. (2015). Canada, Elsevier

    Anaplasmosis and Ehrlichiosis. In Diagnostic Pathology: Infectious Diseases

    Lu, L., and Milner, C. (2015). Canada, Elsevier

    Primary Gram-negative Respiratory Pathogen Infections. In Diagnostic Pathology: Infectious Diseases

    Pecora, N., and Lu, L. (2015). Canada, Elsevier

  • Honors & Awards
    • Young Physician Scientist Award
      American Society for Clinical Investigation (2021)
    • Disease Oriented Clinical Scholars Award
      UT Southwestern (2019)
    • K08 Clinical Scientist Research Career Development Award
      NIH (2017)
    • Maxwell Finland Award for Excellence in Research
      Massachusetts Infectious Disease Society (2017)
    • TB Gift Innovation Award
      The Broad Institute (2017)
  • Professional Associations/Affiliations
    • American Association of Immunology
    • Infectious Diseases Society of America